Myosin light chain7 (Myh7) and calcineurin, which is one of the cardiac hypertrophy and damage markers, were significantly increased in the heart tissue of mRNA-administered groups with or without LPS pump implantation. Here, MYH7 is linked to cardiac hypertrophy.